Esperion Therapeutics
ESPR
ESPR
133 hedge funds and large institutions have $268M invested in Esperion Therapeutics in 2021 Q4 according to their latest regulatory filings, with 44 funds opening new positions, 45 increasing their positions, 26 reducing their positions, and 49 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more ownership
Funds ownership: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
4% less funds holding
Funds holding: 139 → 133 (-6)
10% less first-time investments, than exits
New positions opened: 44 | Existing positions closed: 49
10% less capital invested
Capital invested by funds: $299M → $268M (-$31.1M)
Holders
133
Holding in Top 10
3
Calls
$5.13M
Puts
$3.51M
Top Buyers
| 1 | +$25M | |
| 2 | +$15.6M | |
| 3 | +$12.6M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$9.61M |
| 5 |
MG
Meditor Group
Hamilton,
Bermuda
|
+$8.25M |
Top Sellers
| 1 | -$6.27M | |
| 2 | -$3.54M | |
| 3 | -$1.41M | |
| 4 |
CCM
Cinctive Capital Management
New York
|
-$1.33M |
| 5 |
BNP Paribas Financial Markets
Paris,
France
|
-$1.24M |